Dr. Zevallos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
203 Lothrop St
Ste 500
Pittsburgh, PA 15213Phone+1 412-647-2100Fax+1 412-647-2080
Summary
- Dr. Jose Zevallos, based in Pittsburgh, PA, is an otolaryngologist with a subspecialty in head and neck oncologic surgery. He completed his medical degree at Rutgers New Jersey Medical School, followed by a residency and fellowship in related fields. He also holds an MPH in Epidemiology from the University of Texas School of Public Health. Dr. Zevallos has published several research articles on head and neck cancer and associated topics in reputable journals, and has participated in clinical trials focusing on early detection of HPV-related oropharyngeal cancer.
Education & Training
- University of Texas School of Public HealthMPH, Epidemiology, 2011 - 2014
- Icahn School of Medicine at Mount SinaiFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2010 - 2011
- Baylor College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2005 - 2010
- Baylor College of MedicineInternship, Transitional Year, 2005 - 2006
- Rutgers New Jersey Medical SchoolClass of 2005
Certifications & Licensure
- PA State Medical License 2022 - 2026
- IL State Medical License 2020 - 2023
- MO State Medical License 2017 - 2023
- NC State Medical License 2014 - 2018
- TX State Medical License 2011 - 2015
- NY State Medical License 2010 - 2013
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Clinical Trials
- Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) Start of enrollment: 2024 Jan 22
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsAssociation of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma Patients.Ronan W Hsieh, William E Gooding, Marci Nilsen, Mark Kubik, Zahra Kelly
Clinical Otolaryngology. 2025-01-01 - Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao, Michael B Major, Brittany J Holmes
Clinical Cancer Research. 2024-12-10 - CD8Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A Review.Kevin J Contrera, Matthew E Spector, Liron Pantanowitz, Ibrahim M Abukhiran, Lazar Vujanovic
JCO Precision Oncology. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: